With regards to suicide gene therapy approaches, clinical trials NCT00964756, NCT01997190, and NCT00005025 employed adenoviral or HSV vectors to deliver the TK gene in patients with recurrent ovarian cancer. This evidence concerns the gene TKT and ovarian cancer.